bioAffinity Technologies BIAF

bioAffinity Technologies to hold special meeting

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Special meeting on Nov 20, 2026, at 8:00 a.m. CT
  2. Votes needed for warrant exercise proposals and share reduction
  3. Proxy materials available online starting Oct 23, 2026

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Get an email when bioAffinity Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8731 and related industry codes: the same peer list as the financial tables.